Divya Sagar - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Divya Sagar

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Annals of the Rheumatic Diseases|May 2, 2019

Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosusSaifur Rahman, Divya Sagar, Richard N Hanna, et al.

Lupus Science & Medicine|April 13, 2018

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosusJeffrey M Riggs, Richard N Hanna, Bhargavi Rajan, et al.

Plos One|March 18, 2020

LOX-1: A potential driver of cardiovascular risk in SLE patientsDivya Sagar, Ranjitha Gaddipati, Emily L Ongstad, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Annals of the Rheumatic Diseases|May 2, 2019

Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosusSaifur Rahman, Divya Sagar, Richard N Hanna, et al.

Lupus Science & Medicine|April 13, 2018

Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosusJeffrey M Riggs, Richard N Hanna, Bhargavi Rajan, et al.

Plos One|March 18, 2020

LOX-1: A potential driver of cardiovascular risk in SLE patientsDivya Sagar, Ranjitha Gaddipati, Emily L Ongstad, et al.

Pageof 2